Matches in Nanopublications for { ?s ?p "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP1267131.RARedWdAH2ZLB2EMF7_YT17VhwYh-flKBZN4MtvtxGvfA130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267131.RARedWdAH2ZLB2EMF7_YT17VhwYh-flKBZN4MtvtxGvfA130_provenance.
- NP1267133.RATbhMBE6Qz2oadrP0rIXcePMzDoqW_cYqNlnQz5awpi4130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267133.RATbhMBE6Qz2oadrP0rIXcePMzDoqW_cYqNlnQz5awpi4130_provenance.
- NP1267135.RAen4DIw9yKtDYKDc-4vPVbM4iCz9eYNCZByts89Zi2Uc130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267135.RAen4DIw9yKtDYKDc-4vPVbM4iCz9eYNCZByts89Zi2Uc130_provenance.
- NP1267140.RATLS99ucKouFsVCSVCADe1gyDnSw4-AKmpERTE3rUM94130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267140.RATLS99ucKouFsVCSVCADe1gyDnSw4-AKmpERTE3rUM94130_provenance.
- NP1267134.RAp13E5mgdtIOhs5WR3lrvfz7afgVV_Vlr_E9F2u22bKE130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267134.RAp13E5mgdtIOhs5WR3lrvfz7afgVV_Vlr_E9F2u22bKE130_provenance.
- NP1267136.RAhsEoBENOzfJciXXK1yi5AzKaqa1EO2faRmQHSM2fHek130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267136.RAhsEoBENOzfJciXXK1yi5AzKaqa1EO2faRmQHSM2fHek130_provenance.
- NP1267129.RAIO1_UUaeYkuuh0vtPNmm3w3OxmQaOJE5iMBSX7JXblY130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267129.RAIO1_UUaeYkuuh0vtPNmm3w3OxmQaOJE5iMBSX7JXblY130_provenance.
- NP1267128.RA7QxFQDnXGz7Fba2tu8jEzwl5YydAwnIWQCJv3GiB5cY130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267128.RA7QxFQDnXGz7Fba2tu8jEzwl5YydAwnIWQCJv3GiB5cY130_provenance.
- NP1267130.RAxy9p8m5jkOrWMyvMB-9tNISKfrqsUGoVolunbCWqs8Y130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267130.RAxy9p8m5jkOrWMyvMB-9tNISKfrqsUGoVolunbCWqs8Y130_provenance.
- NP1267132.RA2A6ZGYQxzZ5QedEhI92wh_agNbou9c_ujJvHaZqW3lw130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267132.RA2A6ZGYQxzZ5QedEhI92wh_agNbou9c_ujJvHaZqW3lw130_provenance.
- NP1267137.RAyw8LVt_jBILc2BxlV0B4d0J_cIzulyU8_9V2XxQSJgI130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267137.RAyw8LVt_jBILc2BxlV0B4d0J_cIzulyU8_9V2XxQSJgI130_provenance.
- NP1267138.RA-TFfB-nPkOjG6ES5lCjT_VHdfzlHdhYeLcsLgq7UZkI130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267138.RA-TFfB-nPkOjG6ES5lCjT_VHdfzlHdhYeLcsLgq7UZkI130_provenance.
- NP1267139.RA0xJ3eKWw1nOmGc6jMvNuHWVrW7LaM4NdOEFBGQNiP8c130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267139.RA0xJ3eKWw1nOmGc6jMvNuHWVrW7LaM4NdOEFBGQNiP8c130_provenance.
- NP1267141.RA2-0FXCiLvltLHeMcvk9143_5rxqMe0vZPAVSJS6Ztdc130_assertion description "[Thus, Lewis y leads to inhibition of apoptosis and enhancement of CAM-DR by activation of the FAK signaling pathway and upregulation of Bcl-2/Bcl-XL expression in ovarian cancer cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1267141.RA2-0FXCiLvltLHeMcvk9143_5rxqMe0vZPAVSJS6Ztdc130_provenance.